##GENOME_BUILD=GRCh38
##CREATION_DATE=2022-04-21
##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 2021_12-138-gf7ecace3
##SAMPLE=<ID=NA12878_17,Gender=female,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=Neoplasms,DiseaseStatus=affected>
##FILTER=low_conf_region=Variant marked as 'low_conf_region'.
##DESCRIPTION=NA12878_17=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=SpliceAI=SpliceAI prediction of splice-site variations. Probability of the variant being splice-altering (range from 0-1). The score is the maximum value of acceptor/donor gain/loss of all effected genes.
##DESCRIPTION=PubMed=PubMed ids to publications on the given variant.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
#chr	start	end	ref	obs	NA12878_17	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	CADD	REVEL	MaxEntScan	COSMIC	SpliceAI	PubMed	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr4	89759299	89759300	AA	-	het	low_conf_region	QUAL=619;DP=189;AF=0.02;MQM=60;SAP=3;ABP=272;SAR=9;SAF=9	SNCA	intron,splice_region&intron	SNCA:ENST00000336904.7:intron_variant:MODIFIER:intron4/5:c.307-30023_307-30022del::,SNCA:ENST00000345009.8:intron_variant:MODIFIER:intron3/3:c.307-32640_307-32639del::,SNCA:ENST00000394986.5:intron_variant:MODIFIER:intron4/5:c.307-30023_307-30022del::,SNCA:ENST00000394989.6:intron_variant:MODIFIER:intron3/4:c.265-30023_265-30022del::,SNCA:ENST00000394991.8:intron_variant:MODIFIER:intron4/5:c.307-30023_307-30022del::,SNCA:ENST00000420646.6:intron_variant:MODIFIER:intron4/4:c.307-32640_307-32639del::,SNCA:ENST00000505199.5:intron_variant:MODIFIER:intron2/3:c.265-30023_265-30022del::,SNCA:ENST00000506244.5:intron_variant:MODIFIER:intron4/5:c.307-30023_307-30022del::,SNCA:ENST00000508895.5:intron_variant:MODIFIER:intron4/5:c.307-30023_307-30022del::,SNCA:ENST00000611107.1:intron_variant:MODIFIER:intron2/2:c.265-32640_265-32639del::,SNCA:ENST00000618500.4:intron_variant:MODIFIER:intron3/4:c.265-30023_265-30022del::,SNCA:ENST00000673718.1:intron_variant:MODIFIER:intron6/7:c.307-30023_307-30022del::,SNCA:ENST00000673902.1:intron_variant:MODIFIER:intron4/6:c.307-30023_307-30022del::,SNCA:ENST00000674129.1:splice_region_variant&intron_variant:LOW:intron4/7:c.307-7_307-6del::	SNCA:NM_000345.4:intron_variant:MODIFIER:intron4/5:c.307-30023_307-30022del::,SNCA:NM_001146054.2:intron_variant:MODIFIER:intron4/5:c.307-30023_307-30022del::,SNCA:NM_001146055.2:intron_variant:MODIFIER:intron4/5:c.307-30023_307-30022del::,SNCA:NM_001375285.1:intron_variant:MODIFIER:intron5/6:c.307-30023_307-30022del::,SNCA:NM_001375286.1:intron_variant:MODIFIER:intron4/5:c.307-30023_307-30022del::,SNCA:NM_001375287.1:intron_variant:MODIFIER:intron5/6:c.307-30023_307-30022del::,SNCA:NM_001375288.1:intron_variant:MODIFIER:intron4/5:c.307-30023_307-30022del::,SNCA:NM_001375290.1:intron_variant:MODIFIER:intron1/2:c.162+12097_162+12098del::,SNCA:NM_007308.3:intron_variant:MODIFIER:intron4/4:c.307-32640_307-32639del::,SNCA:NR_164674.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/6:n.385-30023_385-30022del::,SNCA:NR_164675.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/6:n.532-30023_532-30022del::,SNCA:NR_164676.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.605-30023_605-30022del::,SNCA:XM_017008563.1:intron_variant:MODIFIER:intron4/5:c.307-30023_307-30022del::		163890_[GENE=SNCA_PHENOS=Dementia, Lewy body, 127750 (3), Autosomal dominant; Parkinson disease 1, 168601 (3), Autosomal dominant; Parkinson disease 4, 605543 (3), Autosomal dominant]				rs553623713		0.0001	0,.		0.2340			0.39				0		0	2	0 / 0					SNCA (inh=AD oe_syn=1.30 oe_mis=0.85 oe_lof=0.00)
chr4	89838412	89838412	T	-	het		QUAL=0;DP=229;AF=0.04;MQM=60;SAP=9;ABP=0;SAR=2;SAF=7	SNCA-AS1	non_coding_transcript_exon,splice_region&intron&non_coding_transcript	SNCA-AS1:ENST00000501215.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.472del::,SNCA-AS1:ENST00000513653.1:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron2/3:n.473+15del::	SNCA-AS1:NR_045481.1:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron2/3:n.480+15del::	regulatory_region_variant:promoter	163890_[GENE=SNCA_PHENOS=Dementia, Lewy body, 127750 (3), Autosomal dominant; Parkinson disease 1, 168601 (3), Autosomal dominant; Parkinson disease 4, 605543 (3), Autosomal dominant]				rs568487716		0.0008	0,.		-1.0670			0.41						0	12	0 / 3					SNCA (inh=AD oe_syn=1.30 oe_mis=0.85 oe_lof=0.00), SNCA-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr4	89838532	89838532	C	A	het		QUAL=0;DP=321;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=2;SAF=2	SNCA-AS1	non_coding_transcript_exon,intron&non_coding_transcript	SNCA-AS1:ENST00000501215.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.583C>A::,SNCA-AS1:ENST00000513653.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.473+126C>A::	SNCA-AS1:NR_045481.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.480+126C>A::	regulatory_region_variant:promoter	163890_[GENE=SNCA_PHENOS=Dementia, Lewy body, 127750 (3), Autosomal dominant; Parkinson disease 1, 168601 (3), Autosomal dominant; Parkinson disease 4, 605543 (3), Autosomal dominant]									-0.0310			3.36						0	0	0 / 0					SNCA (inh=AD oe_syn=1.30 oe_mis=0.85 oe_lof=0.00), SNCA-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr4	89839024	89839024	T	-	het		QUAL=3424;DP=177;AF=0.14;MQM=60;SAP=14;ABP=201;SAR=7;SAF=18	SNCA-AS1	non_coding_transcript_exon,intron&non_coding_transcript	SNCA-AS1:ENST00000501215.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.1090del::,SNCA-AS1:ENST00000513653.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.473+633del::	SNCA-AS1:NR_045481.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.480+633del::		163890_[GENE=SNCA_PHENOS=Dementia, Lewy body, 127750 (3), Autosomal dominant; Parkinson disease 1, 168601 (3), Autosomal dominant; Parkinson disease 4, 605543 (3), Autosomal dominant]			L1MC5 (LINE/L1)	rs10635705		0.0099	20,.		-2.2790			0.02						1	156	0 / 1					SNCA (inh=AD oe_syn=1.30 oe_mis=0.85 oe_lof=0.00), SNCA-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr4	89839024	89839027	TTTT	-	het		QUAL=3424;DP=177;AF=0.06;MQM=60;SAP=11;ABP=305;SAR=2;SAF=8	SNCA-AS1	non_coding_transcript_exon,intron&non_coding_transcript	SNCA-AS1:ENST00000501215.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.1087_1090del::,SNCA-AS1:ENST00000513653.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.473+630_473+633del::	SNCA-AS1:NR_045481.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.480+630_480+633del::		163890_[GENE=SNCA_PHENOS=Dementia, Lewy body, 127750 (3), Autosomal dominant; Parkinson disease 1, 168601 (3), Autosomal dominant; Parkinson disease 4, 605543 (3), Autosomal dominant]			L1MC5 (LINE/L1)	rs10635705		0.0001	0,.		0.0570			1.14						0	1	0 / 0					SNCA (inh=AD oe_syn=1.30 oe_mis=0.85 oe_lof=0.00), SNCA-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr4	89839024	89839028	TTTTT	-	het		QUAL=3424;DP=177;AF=0.03;MQM=60;SAP=4;ABP=337;SAR=4;SAF=2	SNCA-AS1	non_coding_transcript_exon,intron&non_coding_transcript	SNCA-AS1:ENST00000501215.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.1086_1090del::,SNCA-AS1:ENST00000513653.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.473+629_473+633del::	SNCA-AS1:NR_045481.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.480+629_480+633del::		163890_[GENE=SNCA_PHENOS=Dementia, Lewy body, 127750 (3), Autosomal dominant; Parkinson disease 1, 168601 (3), Autosomal dominant; Parkinson disease 4, 605543 (3), Autosomal dominant]			L1MC5 (LINE/L1)	rs10635705		0.0001	0,.		0.7010			3.05						0	0	0 / 0					SNCA (inh=AD oe_syn=1.30 oe_mis=0.85 oe_lof=0.00), SNCA-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr4	89841795	89841795	C	A	het		QUAL=0;DP=467;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=2;SAF=3	SNCA-AS1	non_coding_transcript_exon	SNCA-AS1:ENST00000513653.1:non_coding_transcript_exon_variant:MODIFIER:exon4/4:n.618C>A::	SNCA-AS1:NR_045481.1:non_coding_transcript_exon_variant:MODIFIER:exon4/4:n.625C>A::		163890_[GENE=SNCA_PHENOS=Dementia, Lewy body, 127750 (3), Autosomal dominant; Parkinson disease 1, 168601 (3), Autosomal dominant; Parkinson disease 4, 605543 (3), Autosomal dominant]									-0.2550			1.88						0	0	0 / 0					SNCA (inh=AD oe_syn=1.30 oe_mis=0.85 oe_lof=0.00), SNCA-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr12	40207957	40207957	C	A	het		QUAL=0;DP=386;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=2;SAF=2	LRRK2-DT,LINC02471	intron&non_coding_transcript,non_coding_transcript_exon	LRRK2-DT:ENST00000412812.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/3:n.145+15702G>T::,LINC02471:ENST00000641941.1:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1290C>A::,LINC02471:ENST00000661406.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.1035C>A::	LOC105369735:XR_944865.3:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.481C>A::											0.5240			3.35						0	0	0 / 0					LINC02471 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), LRRK2-DT (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr12	40209400	40209400	C	A	het		QUAL=0;DP=394;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=2;SAF=2	LRRK2-DT,LINC02471	intron&non_coding_transcript,non_coding_transcript_exon	LRRK2-DT:ENST00000412812.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/3:n.145+14259G>T::,LINC02471:ENST00000641941.1:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.2733C>A::	LOC105369735:XR_944865.3:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.1057C>A::					L2c (LINE/L2)						-0.4250			2.82						0	0	0 / 0					LINC02471 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), LRRK2-DT (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr12	40211201	40211201	C	A	het		QUAL=0;DP=361;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=2;SAF=2	LRRK2-DT,LINC02471	intron&non_coding_transcript,non_coding_transcript_exon	LRRK2-DT:ENST00000412812.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/3:n.145+12458G>T::,LINC02471:ENST00000641941.1:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.4534C>A::						MER4-int (LTR/ERV1)						-0.6990			0.56						0	0	0 / 0					LINC02471 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), LRRK2-DT (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr12	40223394	40223394	C	A	het		QUAL=0;DP=297;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=2;SAF=2	LRRK2-DT	intron&non_coding_transcript,non_coding_transcript_exon	LRRK2-DT:ENST00000412812.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/3:n.145+265G>T::,LRRK2-DT:ENST00000618127.1:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1522G>T::		regulatory_region_variant:promoter	609007_[GENE=LRRK2_PHENOS={Parkinson disease 8}, 607060 (3), Autosomal dominant]			L1MC5 (LINE/L1)						0.7620			4.20						0	0	0 / 0					LRRK2-DT (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), LRRK2 (inh=AD oe_syn=1.02 oe_mis=0.90 oe_lof=0.53)
chr12	40252944	40252944	C	A	het		QUAL=0;DP=388;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=2;SAF=3	LRRK2	missense	LRRK2:ENST00000298910.12:missense_variant:MODERATE:exon11/51:c.1216C>A:p.Leu406Met:,LRRK2:ENST00000343742.6:missense_variant:MODERATE:exon11/27:c.1216C>A:p.Leu406Met:,LRRK2:ENST00000680790.1:missense_variant:MODERATE:exon11/49:c.1216C>A:p.Leu406Met:	LRRK2:NM_198578.4:missense_variant:MODERATE:exon11/51:c.1216C>A:p.Leu406Met:,LRRK2:XM_005268629.4:missense_variant:MODERATE:exon11/51:c.1216C>A:p.Leu406Met:,LRRK2:XM_011537877.3:missense_variant:MODERATE:exon11/50:c.1216C>A:p.Leu406Met:,LRRK2:XM_011537881.3:missense_variant:MODERATE:exon11/34:c.1216C>A:p.Leu406Met:,LRRK2:XM_011537882.3:missense_variant:MODERATE:exon11/28:c.1216C>A:p.Leu406Met:,LRRK2:XM_017018786.2:missense_variant:MODERATE:exon11/32:c.1216C>A:p.Leu406Met:,LRRK2:XM_017018789.2:missense_variant:MODERATE:exon11/29:c.1216C>A:p.Leu406Met:,LRRK2:XM_024448833.1:missense_variant:MODERATE:exon2/42:c.13C>A:p.Leu5Met:,LRRK2:XR_001748574.2:non_coding_transcript_exon_variant:MODIFIER:exon11/37:n.1458C>A::		609007_[GENE=LRRK2_PHENOS={Parkinson disease 8}, 607060 (3), Autosomal dominant]									1.3540	T(0.06),T(0.07),T(0.09)	D(1.00),D(1.00),B(0.10)	19.00	0.19			0.01		0	0	0 / 0					LRRK2 (inh=AD oe_syn=1.02 oe_mis=0.90 oe_lof=0.53)
chr12	40263883	40263883	C	A	het		QUAL=0;DP=371;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=2;SAF=2	LRRK2	synonymous	LRRK2:ENST00000298910.12:synonymous_variant:LOW:exon14/51:c.1638C>A:p.Val546=:,LRRK2:ENST00000343742.6:synonymous_variant:LOW:exon14/27:c.1638C>A:p.Val546=:,LRRK2:ENST00000680790.1:synonymous_variant:LOW:exon12/49:c.1383C>A:p.Val461=:	LRRK2:NM_198578.4:synonymous_variant:LOW:exon14/51:c.1638C>A:p.Val546=:,LRRK2:XM_005268629.4:synonymous_variant:LOW:exon14/51:c.1638C>A:p.Val546=:,LRRK2:XM_011537877.3:synonymous_variant:LOW:exon14/50:c.1638C>A:p.Val546=:,LRRK2:XM_011537881.3:synonymous_variant:LOW:exon14/34:c.1638C>A:p.Val546=:,LRRK2:XM_011537882.3:synonymous_variant:LOW:exon14/28:c.1638C>A:p.Val546=:,LRRK2:XM_017018786.2:synonymous_variant:LOW:exon14/32:c.1638C>A:p.Val546=:,LRRK2:XM_017018789.2:synonymous_variant:LOW:exon14/29:c.1638C>A:p.Val546=:,LRRK2:XM_024448833.1:synonymous_variant:LOW:exon5/42:c.435C>A:p.Val145=:,LRRK2:XR_001748574.2:non_coding_transcript_exon_variant:MODIFIER:exon14/37:n.1880C>A::	regulatory_region_variant:promoter_flanking_region	609007_[GENE=LRRK2_PHENOS={Parkinson disease 8}, 607060 (3), Autosomal dominant]									0.3700			7.80				0.01		0	0	0 / 0					LRRK2 (inh=AD oe_syn=1.02 oe_mis=0.90 oe_lof=0.53)
chr12	40274668	40274668	C	A	het		QUAL=0;DP=355;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=2;SAF=2	LRRK2	missense	LRRK2:ENST00000298910.12:missense_variant:MODERATE:exon15/51:c.1742C>A:p.Ser581Tyr:,LRRK2:ENST00000343742.6:missense_variant:MODERATE:exon15/27:c.1742C>A:p.Ser581Tyr:,LRRK2:ENST00000680790.1:missense_variant:MODERATE:exon13/49:c.1487C>A:p.Ser496Tyr:	LRRK2:NM_198578.4:missense_variant:MODERATE:exon15/51:c.1742C>A:p.Ser581Tyr:,LRRK2:XM_005268629.4:missense_variant:MODERATE:exon15/51:c.1742C>A:p.Ser581Tyr:,LRRK2:XM_011537877.3:missense_variant:MODERATE:exon15/50:c.1742C>A:p.Ser581Tyr:,LRRK2:XM_011537881.3:missense_variant:MODERATE:exon15/34:c.1742C>A:p.Ser581Tyr:,LRRK2:XM_011537882.3:missense_variant:MODERATE:exon15/28:c.1742C>A:p.Ser581Tyr:,LRRK2:XM_017018786.2:missense_variant:MODERATE:exon15/32:c.1742C>A:p.Ser581Tyr:,LRRK2:XM_017018789.2:missense_variant:MODERATE:exon15/29:c.1742C>A:p.Ser581Tyr:,LRRK2:XM_024448833.1:missense_variant:MODERATE:exon6/42:c.539C>A:p.Ser180Tyr:,LRRK2:XR_001748574.2:non_coding_transcript_exon_variant:MODIFIER:exon15/37:n.1984C>A::		609007_[GENE=LRRK2_PHENOS={Parkinson disease 8}, 607060 (3), Autosomal dominant]									3.5310	T(0.13),D(0.02),T(0.07)	P(0.73),P(0.56),B(0.41)	21.30	0.21		COSV54155082	0.01		0	0	0 / 0					LRRK2 (inh=AD oe_syn=1.02 oe_mis=0.90 oe_lof=0.53)
chr12	40274835	40274835	T	-	het		QUAL=0;DP=452;AF=0.03;MQM=60;SAP=4;ABP=0;SAR=8;SAF=6	LRRK2	intron	LRRK2:ENST00000298910.12:intron_variant:MODIFIER:intron15/50:c.1802-11del::,LRRK2:ENST00000343742.6:intron_variant:MODIFIER:intron15/26:c.1802-11del::,LRRK2:ENST00000680790.1:intron_variant:MODIFIER:intron13/48:c.1547-11del::	LRRK2:NM_198578.4:intron_variant:MODIFIER:intron15/50:c.1802-11del::,LRRK2:XM_005268629.4:intron_variant:MODIFIER:intron15/50:c.1802-11del::,LRRK2:XM_011537877.3:intron_variant:MODIFIER:intron15/49:c.1802-11del::,LRRK2:XM_011537881.3:intron_variant:MODIFIER:intron15/33:c.1802-11del::,LRRK2:XM_011537882.3:intron_variant:MODIFIER:intron15/27:c.1802-11del::,LRRK2:XM_017018786.2:intron_variant:MODIFIER:intron15/31:c.1802-11del::,LRRK2:XM_017018789.2:intron_variant:MODIFIER:intron15/28:c.1802-11del::,LRRK2:XM_024448833.1:intron_variant:MODIFIER:intron6/41:c.599-11del::,LRRK2:XR_001748574.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron15/36:n.2044-11del::		609007_[GENE=LRRK2_PHENOS={Parkinson disease 8}, 607060 (3), Autosomal dominant]				rs200529791		0.0005	0,.	0.0015,0.0002,0.0001,0.0001,0.0001	0.5900			1.92				0.01		0	9	0 / 1					LRRK2 (inh=AD oe_syn=1.02 oe_mis=0.90 oe_lof=0.53)
chr12	40287550	40287550	-	AA	het		QUAL=4207;DP=352;AF=0.45;MQM=60;SAP=4;ABP=683;SAR=4;SAF=6	LRRK2	intron	LRRK2:ENST00000298910.12:intron_variant:MODIFIER:intron20/50:c.2689+19_2689+20dup::,LRRK2:ENST00000343742.6:intron_variant:MODIFIER:intron20/26:c.2689+19_2689+20dup::,LRRK2:ENST00000680790.1:intron_variant:MODIFIER:intron18/48:c.2434+19_2434+20dup::	LRRK2:NM_198578.4:intron_variant:MODIFIER:intron20/50:c.2689+19_2689+20dup::,LRRK2:XM_005268629.4:intron_variant:MODIFIER:intron20/50:c.2689+19_2689+20dup::,LRRK2:XM_011537877.3:intron_variant:MODIFIER:intron20/49:c.2689+19_2689+20dup::,LRRK2:XM_011537881.3:intron_variant:MODIFIER:intron20/33:c.2689+19_2689+20dup::,LRRK2:XM_011537882.3:intron_variant:MODIFIER:intron20/27:c.2689+19_2689+20dup::,LRRK2:XM_017018786.2:intron_variant:MODIFIER:intron20/31:c.2689+19_2689+20dup::,LRRK2:XM_017018789.2:intron_variant:MODIFIER:intron20/28:c.2689+19_2689+20dup::,LRRK2:XM_024448833.1:intron_variant:MODIFIER:intron11/41:c.1486+19_1486+20dup::,LRRK2:XR_001748574.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron20/36:n.2931+19_2931+20dup::		609007_[GENE=LRRK2_PHENOS={Parkinson disease 8}, 607060 (3), Autosomal dominant]				rs66810434		0.0013	1,.	0.0059,0.0002,0.0000,0.0003,0.0001				0.18				0		0	4	0 / 0					LRRK2 (inh=AD oe_syn=1.02 oe_mis=0.90 oe_lof=0.53)
chr12	40305768	40305768	T	-	het		QUAL=0;DP=409;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=3;SAF=2	LRRK2	intron	LRRK2:ENST00000298910.12:intron_variant:MODIFIER:intron27/50:c.3778-10del::,LRRK2:ENST00000680790.1:intron_variant:MODIFIER:intron25/48:c.3523-10del::	LRRK2:NM_198578.4:intron_variant:MODIFIER:intron27/50:c.3778-10del::,LRRK2:XM_005268629.4:intron_variant:MODIFIER:intron27/50:c.3778-10del::,LRRK2:XM_011537877.3:intron_variant:MODIFIER:intron27/49:c.3778-10del::,LRRK2:XM_011537881.3:intron_variant:MODIFIER:intron27/33:c.3778-10del::,LRRK2:XM_011537882.3:intron_variant:MODIFIER:intron27/27:c.3777+1641del::,LRRK2:XM_017018786.2:intron_variant:MODIFIER:intron27/31:c.3778-10del::,LRRK2:XM_017018787.1:intron_variant:MODIFIER:intron6/29:c.694-10del::,LRRK2:XM_017018788.2:intron_variant:MODIFIER:intron2/25:c.40-10del::,LRRK2:XM_017018789.2:intron_variant:MODIFIER:intron28/28:c.*17-10del::,LRRK2:XM_024448833.1:intron_variant:MODIFIER:intron18/41:c.2575-10del::,LRRK2:XR_001748574.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron27/36:n.4020-10del::		609007_[GENE=LRRK2_PHENOS={Parkinson disease 8}, 607060 (3), Autosomal dominant]				rs747881946		0.0001	0,.	0.0001,0.0000,0.0000,0.0001,0.0000	-0.1550			1.04				0.21		0	0	0 / 0					LRRK2 (inh=AD oe_syn=1.02 oe_mis=0.90 oe_lof=0.53)
chr12	40310458	40310458	C	A	het		QUAL=0;DP=541;AF=0.01;MQM=60;SAP=3;ABP=0;SAR=3;SAF=3	LRRK2	missense	LRRK2:ENST00000298910.12:missense_variant:MODERATE:exon31/51:c.4345C>A:p.Leu1449Ile:PF08477 [Ras of Complex Roc domain of DAPkinase],LRRK2:ENST00000680790.1:missense_variant:MODERATE:exon29/49:c.4090C>A:p.Leu1364Ile:PF08477 [Ras of Complex Roc domain of DAPkinase]	LRRK2:NM_198578.4:missense_variant:MODERATE:exon31/51:c.4345C>A:p.Leu1449Ile:,LRRK2:XM_005268629.4:missense_variant:MODERATE:exon31/51:c.4345C>A:p.Leu1449Ile:,LRRK2:XM_011537877.3:missense_variant:MODERATE:exon31/50:c.4345C>A:p.Leu1449Ile:,LRRK2:XM_011537881.3:missense_variant:MODERATE:exon31/34:c.4345C>A:p.Leu1449Ile:,LRRK2:XM_017018786.2:missense_variant:MODERATE:exon31/32:c.4345C>A:p.Leu1449Ile:,LRRK2:XM_017018787.1:missense_variant:MODERATE:exon10/30:c.1261C>A:p.Leu421Ile:,LRRK2:XM_017018788.2:missense_variant:MODERATE:exon6/26:c.607C>A:p.Leu203Ile:,LRRK2:XM_024448833.1:missense_variant:MODERATE:exon22/42:c.3142C>A:p.Leu1048Ile:,LRRK2:XR_001748574.2:non_coding_transcript_exon_variant:MODIFIER:exon31/37:n.4587C>A::		609007_[GENE=LRRK2_PHENOS={Parkinson disease 8}, 607060 (3), Autosomal dominant]									5.3640	D(0.01),D(0.01)	P(0.87),P(0.77)	23.30	0.31		COSV54153364	0		0	0	0 / 0					LRRK2 (inh=AD oe_syn=1.02 oe_mis=0.90 oe_lof=0.53)
chr12	40359242	40359242	-	TT	het	low_conf_region	QUAL=4492;DP=228;AF=0.09;MQM=60;SAP=8;ABP=333;SAR=7;SAF=14	LRRK2	intron	LRRK2:ENST00000298910.12:intron_variant:MODIFIER:intron46/50:c.6844-9_6844-8dup::,LRRK2:ENST00000680790.1:intron_variant:MODIFIER:intron44/48:c.6589-9_6589-8dup::	LRRK2:NM_198578.4:intron_variant:MODIFIER:intron46/50:c.6844-9_6844-8dup::,LRRK2:XM_005268629.4:intron_variant:MODIFIER:intron46/50:c.6844-9_6844-8dup::,LRRK2:XM_011537877.3:intron_variant:MODIFIER:intron46/49:c.6844-9_6844-8dup::,LRRK2:XM_017018787.1:intron_variant:MODIFIER:intron25/29:c.3760-9_3760-8dup::,LRRK2:XM_017018788.2:intron_variant:MODIFIER:intron21/25:c.3106-9_3106-8dup::,LRRK2:XM_024448833.1:intron_variant:MODIFIER:intron37/41:c.5641-9_5641-8dup::,LOC105369736:XR_944868.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/5:n.485-4417_485-4416dup::		609007_[GENE=LRRK2_PHENOS={Parkinson disease 8}, 607060 (3), Autosomal dominant]	1198506 [likely benign DISEASE=not provided];			rs72546334		0.0273	2,.	0.0238,0.0222,0.0231,0.0308,0.0260				5.79				0.03	20506312	0	53	0 / 3					LRRK2 (inh=AD oe_syn=1.02 oe_mis=0.90 oe_lof=0.53)
